Please use this identifier to cite or link to this item:
https://rima.ufrrj.br/jspui/handle/20.500.14407/14212
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Queiroz, Ana Paula Antunes de | |
dc.date.accessioned | 2023-12-22T02:57:32Z | - |
dc.date.available | 2023-12-22T02:57:32Z | - |
dc.date.issued | 2013-09-25 | |
dc.identifier.citation | QUEIROZ, Ana Paula Antunes de. Efeitos da alteração do status tireoidiano no modelo de isquemia-reperfusão de corações isolados de ratos. 2013. 60 f. Tese (Doutorado em Medicina Veterinária, Patologia e Ciências Clínicas) - Instituto de Veterinária, Universidade Federal Rural do Rio de Janeiro, Seropédica, 2013. | por |
dc.identifier.uri | https://rima.ufrrj.br/jspui/handle/20.500.14407/14212 | - |
dc.description.abstract | O HT (hormônio tireoidiano) possui importante p apel na homeostase do organismo. Os HTs sofrem influência direta do eixo hipotálamo hipófise tireóide e a também das desiodases. Com relação ao coração, este sofre influência direta e indireta dos HTs. Diversos genes cardíacos podem ser modulados pelos HTs no sentido do aumento da contratilidade miocárdica. O excesso dos HT s est á associado com: aumento do débito cardíaco, aumento da frequência e contratilidade cardíaca s em humanos e animais. Os HTs em excesso podem levar a falência cardíaca em pacientes hip ertireoideos. A redução crônica do HT leva a disfunção e dilatação da câmara ventricular, bradicardia, injúria na contratilidade cardíaca e com isso redução do débito cardíaco. Assim, há informações a serem esclarecidas com relação ao coração associado s co m hipertireoidismo e hipotireoidismo. Em um estudo, o hipotireoidismo foi induzido pelo modelo de infarto do miocárdio em ratos (Olivares et al ., 2007), sendo que esta mesma condição ocorreu em cardiopatias clínicas. Neste estudo, o hipotireoidismo foi ass ociado com a indução da desiodase tipo 3, principal via catabólica do HT no coração infartado. Assim é preciso ser esclarecido se o hipotireoidismo pós infarto seria uma adaptação do coração doente ou se faria parte do desenvolvimento da doença miocárdica. Para responder essa questão, estudamos a influência no coração da hipertireotoxicose induzida por T4 e do hipotireoidismo induzido por metimazol. Os grupos experimentais foram compostos por ratos Wistar machos, sendo divididos em grupos controle, grupo T4 e grupo MMZ. Após o tratamento, os animais foram eutanasiados, tiveram o sangue coletado para dosagens de T4 e T3 séricos pela técnica de radioimunoensaio e seus corações retirados rapidamente e colocados num sistema de coração isolado pela técnica de Lan gendorff modificada. As avaliações funcionais foram: eletrocardiograma; pressões diastólica e sistólica finais e pressão desenvolvida pelo ventrículo esquerdo que foram gravadas durante o experimento com coração isolado . Posteriormente, os corações foram s ubmetidos ao modelo de isquemia reperfusão global, já bem descrito na literatura. Após o experimento no coração isolado, este foi submetido à avaliação histopatológica, principalmente para o estudo da área de isquemia. Os dados foram analisados pelo progra ma ANOVA seguido do teste de Bonferoni com o auxílio do programa GhraphPad (versão 5 0). E os resultados foram representados como média ± erro padrão da média e as diferenças foram consideradas significativas se P < 0.05 . Os resultados sugeriram que o HT elevado causou hipertrofia cardíaca, melhora na PDVE na reperfusão e não alterou a área de infarto. Porém o HT elevado tornou os corações mais susceptíveis a fibrilação. No entanto o nível demasiadamente reduzido de HT foi deletério ao coração que sofreu injuria de reperfusão , porém reduziu o índice de fibrilação cardíaca . Pode se concluir que níve l aumentado do HT pode ser cardioprotetor contra à injuria de isquemia e reperfusão no entanto, torna o coração mais sensível a arritmias fatais. Por outro la do, embora os padrões funcionais reduzidos, o hipotireoidismo diminuiu as chances de fibrilação após isquemia e reperfusão miocárdica. Porém mais estudos devem ser realizados para se determinar com maior precisão o papel da alteração do status tireoidiano no coração submetido a isquemia. | por |
dc.description.sponsorship | Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, CAPES, Brasil. | por |
dc.format | application/pdf | * |
dc.language | por | por |
dc.publisher | Universidade Federal Rural do Rio de Janeiro | por |
dc.rights | Acesso Aberto | por |
dc.subject | hormônio tireoidiano | por |
dc.subject | coração | por |
dc.subject | isquemia | por |
dc.subject | thyroid hormone | eng |
dc.subject | heart | eng |
dc.subject | ischemia | eng |
dc.title | Efeitos da alteração do status tireoidiano no modelo de isquemia-reperfusão de corações isolados de ratos | por |
dc.title.alternative | Effects of alterations in thyroid status on myocardial ischemia-reperfusion injurie in isolated rat hearts | eng |
dc.type | Tese | por |
dc.description.abstractOther | The TH (thyroid hormone ) plays an important role in homeostasis. The THs suffer direct influence of the hypothalamic pituitary thyroid and also the deiodinases. With respect to the heart, it suffers direct and indirect influence of THs. Several cardiac genes can be modulated by THs towards increased myocardial contractility. Excess of the TH is associated with: increased cardiac output, increased heart rate and cardiac contractility in humans and animals. The THs excess can lead to heart failure in hyperthyroid patients. The reduction of the TH leads to chronic dysfunction and ventricul ar chamber dilation, bradycardia, cardiac contractility injury and thus reduced cardiac output. Thus, there are informations to be clarified with respect to the heart associated with hyperthyroidism and hypothyroidism. In one study, hypothyroidism was indu ced model of myocardial infarction in rats (Olivares et al., 2007), and this same condition occurred in cardiac clinics. In this study, hypothyroidism was associated with induction of type 3 deiodinase, the main catabolic pathway of TH in infarcted heart. So we must be clear whether hypothyroidism post infarction was an adaptation of the diseased heart or would be part of the development of myocardial disease. To answer this question, we studied the influence in the heart about tireotoxicose induced T4 and hypothyroidism induced by methimazole. The experimental groups were composed of male Wistar rats were divided into control group, T4 group and MMZ group. After the treatment, the animals were euthanized, had blood collected for determination of serum T4 an d T3 by radioimmunoassay and their hearts rapidly removed and placed in a isolated heart system by the modified Langendorff technique. Functional evaluations were eletrocardiogram; end diastolic and systolic pressure, developed pressure by the left ventric le. Subsequently, the hearts were subjected to ischemia reperfusion model of global, already well described in the literature. After the experimen t in the isolated heart, this was subjected to histopathological evaluation, mainly to study the area of ischemia. The d ata were analyzed by ANOVA followed by Bonferoni test with the help of the program GhraphPad (version 5.0). And the results were repre sented as mean ± standard error of the mean, and differences were considered significant if P < 0 05. The results suggested that the high HT caused cardiac hypertrophy, improved PDVE reperfusion and did not alter infarct ed area . But the high HT become the hearts more susceptible to fibrillation. However the critically low level of HT was deleterious to the heart that has suffered injury reperfusion, but decreased the rate of cardiac fibrillation. It can be concluded that increased level of HT may be cardiop rotective against the ischemia reperfusion injury, however, renders the heart more susceptible to fatal arrhythmias. Moreover, although the reduced functional mechanical parameters , hypothyroidism decreased the chances of fibrillation after myocardial isch emia and reperfusion. But more studies should be conducted to determine more precisely the role of the change of thyroid status in the heart subjected to ischemia and reperfusion. | eng |
dc.contributor.advisor1 | Olivares, Emerson Lopes | |
dc.contributor.advisor1ID | 027.886.707-37 | por |
dc.contributor.advisor1Lattes | http://lattes.cnpq.br/1361659701207857 | por |
dc.creator.ID | 079.630.617-60 | por |
dc.creator.Lattes | http://lattes.cnpq.br/8530443731842815 | por |
dc.publisher.country | Brasil | por |
dc.publisher.department | Instituto de Veterinária | por |
dc.publisher.initials | UFRRJ | por |
dc.publisher.program | Programa de Pós-Graduação em Medicina Veterinária (Patologia e Ciências Clínicas) | por |
dc.relation.references | ARAUJO, A.S .; RIBEIRO, M.F .; ENZVEILER, A .; SCHENKEL, P .; FERNANDES, T.R .; PARTATA, W.A .; IRIGOYEN, M.C .; LLESUY, S .; BELLÓ KLEIN, A . Myocardial antioxidant enzyme activities and concentration and glutathione metabolism in experimental hyperthyroidism. Mol Cell Endocrinol ., v. 249, n. 1 2, p. 133 9, abril 2006. ARAUJO, A.S .; SCHENKEL, P .; ENZVEILER, A.T .; FERNANDES, T.R .; PARTATA, W.A .; LLESUY, S .; RIBEIRO, M.F .; KHAPER, N .; SINGAL, P.K .; BELLÓ KLEIN, A . The role of redox signaling in cardiac hypertrophy induced by experimental hyperthyr oidism. J mol endocrinol.endocrinol., v. 41 n. 6, p. 423 30, dez 2008. ARROJO, E DRIGO, R .; BIANCO, A.C . Type 2 deiodinase at the crossroads of thyroid hormone action. Int J Biochem Cell Biol ., v. 43, n. 10, p. 1432 41, jun 2012. ARROJO E DRIGO, R .; FONSECA, T.L .; WERNECK DE CASTRO, J.P .; BIANCO, A.C . Role of the type 2 iodothyronine deiodinase (D2) in the control of thyroid hormone signaling. Biochim Biophys Acta , v. 1830, n.7, p.3956 64, jul 2013. ASRANNA, A .; TANEJA, R.S .; KULSHRESHTA, B . Dyslipidemia in subclinical hypothyroidism a nd the effect of thyroxine on lipid profile. Indian J Endocrinol Metab., v.16, n. 2, p. 347 349 , dez 2012. ASVOLD, B.O.; BJORO, T.; NILSEN, T.I.; GUNNELL, D.; VATTEN, L.J. Thyrotropin levels and risk of fatal coronary heart disease: the HUNT study. Arch I nternMed , 168, n.8, p. 855 860, abril 2008. BANDYOPADHYAY, U .; BISWAS, K .; BANERJEE, R.K . Extrathyroidal actions of antithyroid thionamides. Toxicol Lett , v. 128, n. 1 3, p. 117 27, , mar 2002. BARALDI, D .; CASALI, K .; FERNANDES, R.O .; CAMPOS, C .; SARTÓRIO, C .; CONZATTI, A .; COUTO, G.K .; SCHENKEL, P.C .; BELLÓ KLEIN, A .; ARAUJO, A.R .The role of AT1 receptor blockade on reactive oxygen species and cardiac autonomic drive in experimental hyperthyroidism. Auton Neurosci Abr 2013. BIANCO, S. D. C ; KIM, B. W.; ZHANG, J. X ; HARNEY, J. W. ; RIBEIRO, R.S. ; GEREBEN, B.; BIANCO, A. C.; MENDE, U.; LARSEN, P. R. Chronic Cardiac Specific Thyrotoxicosis Incre ases Myocardial β Adrenergic Responsiveness. Molecular Endocrinology , v. 18, n. p. 1840 1849, jul 2004. BIONDI B; KLEIN I. Hypothyroidism as a risk factor for cardiovascular disease. Endocrine, v. 24, n. 1, p.1 13, jun 2004. BOBADILLA, I .; FRANCO, M .; CRUZ, D .; ZAMORA, J .; ROBLES, S.G .; CHÁVEZ, E . Hypothyroidism provides resistance to reperfusion injury following myocardium ischemia. Int. J. Biochem. Cell. Biol. v.33, n. 5. P. 499 506, mai 2001. CANO EUROPA, E .; BLAS VALDIVIA, V .; FRANCO COLIN, M .; GALLARDO CASAS, 51 C.AC.A.; .; ORTIZORTIZ--BUTRÓN, RBUTRÓN, R. . MethMethimazoleimazole--induced hypothyroidism causes cellular damage in induced hypothyroidism causes cellular damage in the spleen, heart, liver, lung and kidney. the spleen, heart, liver, lung and kidney. Acta HistochemActa Histochem..,, v. 113, n. 1,p. 1v. 113, n. 1,p. 1--5, jan 2011.5, jan 2011. CARNEIROCARNEIRO--RAMOS, M.SRAMOS, M.S.; .; DINIZ, G.PDINIZ, G.P.; .; ALMEIDA, JALMEIDA, J.; .; VIEIRA, R.LVIEIRA, R.L.; .; PINHEIRO, S.VPINHEIRO, S.V.; .; SANTOS, R.ASANTOS, R.A.; .; BARRETOBARRETO--CHAVES, M.LCHAVES, M.L. . Cardiac angioCardiac angiotensin II type I and type II tensin II type I and type II receptors are increased in rats submitted to experimental hypothyroidism. receptors are increased in rats submitted to experimental hypothyroidism. J. PhysiolJ. Physiol.. , v.583, , v.583, p. 213p. 213--23, mai 2007.23, mai 2007. CARVALHO CARVALHO--BIANCO, S.DBIANCO, S.D.; .; KIM, B.WKIM, B.W.; .; ZHANG, J.XZHANG, J.X.; .; HARNEY, J.WHARNEY, J.W.; .; RIBEIRO, R.SRIBEIRO, R.S.; .; GEREBEN, BGEREBEN, B.; .; BIANCO, A.CBIANCO, A.C.; .; MENDE, UMENDE, U.; .; LARSEN, P.RLARSEN, P.R. Chronic Cardiac. Chronic Cardiac--Specific Specific TThyrotoxicosis Increaseshyrotoxicosis Increases-- Myocardial Myocardial --Adrenergic Responsiveness. Adrenergic Responsiveness. Mol EndocrinolMol Endocrinol, v.18, n. , v.18, n. 7, p.18407, p.1840--9, jul 2004.9, jul 2004. CHANG, K.C.; FIGUEREDO, V.M.; SCHREUR, J.H.; KARIYA, K.; WEINER, M.W.; CHANG, K.C.; FIGUEREDO, V.M.; SCHREUR, J.H.; KARIYA, K.; WEINER, M.W.; SIMPSON, P.C.; CAMACHO, S.A. Thyroid hormone improves function and Ca SIMPSON, P.C.; CAMACHO, S.A. Thyroid hormone improves function and Ca 2+2+ handling handling in pressure overload hypertrophy. Association with increased sarcoplasmic reticulum Ca in pressure overload hypertrophy. Association with increased sarcoplasmic reticulum Ca 2+2+ --ATPaseATPase and alphaand alpha--myosin heavy chain in rat hearts. myosin heavy chain in rat hearts. J. Clin. InvestJ. Clin. Invest, v. 100, n. 7, p. 1742, v. 100, n. 7, p. 1742––9, out 9, out 19971997.. CHEN, W.JCHEN, W.J.;.;YEH, Y.HYEH, Y.H.; .; LIN, K.HLIN, K.H.; .; CHANG, G.JCHANG, G.J.; .; KUO, C.TKUO, C.T. Molecular characterization of . Molecular characterization of thyroid hormonethyroid hormone--inhibited atrial Linhibited atrial L--type calcium channel expression: implication for atrial type calcium channel expression: implication for atrial fibrillation in hyperthyroidism. fibrillation in hyperthyroidism. Basic Res CardiolBasic Res Cardiol, v. 106, n. 2, p. 163, v. 106, n. 2, p. 163--164, Mar 2011.164, Mar 2011. CHEN, Y.FCHEN, Y.F; ; KOBAYASHI, SKOBAYASHI, S.; .; CHEN, JCHEN, J.; .; REDETZKE, R.AREDETZKE, R.A.; .; SAID, SSAID, S.; .; LIANG, QLIANG, Q.; .; GERDES, A.MGERDES, A.M. Short term triiodo. Short term triiodo--LL--thyronine treatment inhibits cardiac myocyte apoptosis thyronine treatment inhibits cardiac myocyte apoptosis in border area after myocardial infarction in rats. in border area after myocardial infarction in rats. J. Mol. Cell. CardiolJ. Mol. Cell. Cardiol.., v. 44, n. 1, p. 180, v. 44, n. 1, p. 180--7, 7, jan 2008.jan 2008. CHEN, Y.F.; REDETZKE, R.A.; SAI CHEN, Y.F.; REDETZKE, R.A.; SAID, S.; BEYER, A.J.; GERDES, A.M. D, S.; BEYER, A.J.; GERDES, A.M. Changes in left Changes in left ventricular function and remodeling after myocardial infarction in hypothyroid rats.ventricular function and remodeling after myocardial infarction in hypothyroid rats. Am J Am J Physiol Heart Circ PhysiolPhysiol Heart Circ Physiol, v. 298, n. 1, p. 259, v. 298, n. 1, p. 259--62, jan 62, jan 2010.2010. CHESS CHESS--WILLIAMS, RWILLIAMS, R.; .; COKER, S.JCOKER, S.J. Ventricular fibrillation is reduced in hypothyroid rats . Ventricular fibrillation is reduced in hypothyroid rats with enhanced myocardial alphawith enhanced myocardial alpha--adrenoceptor responsiveness.adrenoceptor responsiveness. BrBr.. JJ.. PharmacolPharmacol, v. 98, n. 1, p. , v. 98, n. 1, p. 9595--100, set 1989.100, set 1989. CHOI, Y.HCHOI, Y.H.; .; CHUNG, J.HCHUNG, J.H.; .; BAE, S.WBAE, S.W.; .; LEE, LEE, ; ; JEONG, E.MJEONG, E.M.; .; KANG, M.GKANG, M.G.; .; KIM, B.JKIM, B.J.; .; KIM, KIM, K.WK.W.; .; PPARK, J.EARK, J.E. Severe coronary artery spasm can be associated with hyperthyroidism. . Severe coronary artery spasm can be associated with hyperthyroidism. Coron. Artery DisCoron. Artery Dis.., v.16, n. 3, p. 135, v.16, n. 3, p. 135--9., mai 2005.9., mai 2005. COTOMACCI, G COTOMACCI, G., ., SARKIS, J.JSARKIS, J.J., ., FÜRSTENAU, C.RFÜRSTENAU, C.R., ., BARRETOBARRETO--CHAVES, M.LCHAVES, M.L. Thy. Thyroid roid hormones are involved in 5'hormones are involved in 5'--nucleotidase modulation in soluble fraction of cardiac tissue. nucleotidase modulation in soluble fraction of cardiac tissue. Life Life Sci.Sci., v. 91, n. 3, v. 91, n. 3--4, p.1374, p.137--42, ago 2012.42, ago 2012. CROSS, H.RCROSS, H.R.; .; OPIE, L.HOPIE, L.H.; .; RADDA, G.KRADDA, G.K.; .; CLARKE, KCLARKE, K .Is a high glycogen content .Is a high glycogen content beneficial or detrimental to the ischemic rat heart? A controversy resolved. beneficial or detrimental to the ischemic rat heart? A controversy resolved. Circ ResCirc Res.., v, v. 78 .n . 78 .n 3, p. 4823, p. 482--91, mar 1996.91, mar 1996. 52 DAVIS, P. J.; LEONARD, J. L; DAVIS; F.B. Mechanisms of nongenomic actions of thyroid DAVIS, P. J.; LEONARD, J. L; DAVIS; F.B. Mechanisms of nongenomic actions of thyroid hormone. hormone. Front NeuroendocrinolFront Neuroendocrinol, v. 29, v. 29, n. 2, p. 211, n. 2, p. 211--8, mai 2008.8, mai 2008. EVERETT, A.W.; SINHA, A.M.; UMEDA, P.K.; JAKOVCIC, S.; RABINOWITZ, M.; ZAK, EVERETT, A.W.; SINHA, A.M.; UMEDA, P.K.; JAKOVCIC, S.; RABINOWITZ, M.; ZAK, R. Regulation of myosin synthesis by thyroid hormone: relative change in the alphaR. Regulation of myosin synthesis by thyroid hormone: relative change in the alpha--and betaand beta--myosin heavy chain mRNA levels in rabbit heart. myosin heavy chain mRNA levels in rabbit heart. BiochemistrBiochemistry,y, v. 23, n. 8, p. 1596v. 23, n. 8, p. 1596––1599, 1599, abril 1984.abril 1984. FAZIO, S FAZIO, S.; .; PALMIERI, E.APALMIERI, E.A.; .; LOMBARDI, GLOMBARDI, G.; .; BIONDI, BBIONDI, B. Effects of thyroid hormone on . Effects of thyroid hormone on the cardiovascular system. the cardiovascular system. Recent Prog Horm ResRecent Prog Horm Res. , v. 59, p. 31. , v. 59, p. 31--50, 2004.50, 2004. FRANK, A; FRANK, A; BONNEY, M.; BONNEY, S.; WEITZEL, L.; KOEPPEN, M.; ECKLE, T. BONNEY, M.; BONNEY, S.; WEITZEL, L.; KOEPPEN, M.; ECKLE, T. Myocardial ischemia reperfusion injury Myocardial ischemia reperfusion injury -- from basfrom basic science to clinical bedside. ic science to clinical bedside. Semin Semin Cardiothorac Vasc Anesth.Cardiothorac Vasc Anesth., v. 16, n. 3, p. 123, v. 16, n. 3, p. 123--32, set 201232, set 2012.. GERDES, A. M. ; IERVASI, G.Thyroid ReplacGERDES, A. M. ; IERVASI, G.Thyroid Replacement Therapy and Heart Failure.ement Therapy and Heart Failure.CirculationCirculation.. , , v. 122, n. 4, p. 385v. 122, n. 4, p. 385--93, jul 2010.93, jul 2010. GOMBERGGOMBERG--MAITLAND, M.; FRISHMAN, W.H. Thyroid hormone and cardiovascular MAITLAND, M.; FRISHMAN, W.H. Thyroid hormone and cardiovascular disease. disease. Am. Heart JAm. Heart J., ., n. 135, p. 187n. 135, p. 187--196, fev 1998.196, fev 1998. GROVER, G.JGROVER, G.J.; .; MELLSTRÖM, KMELLSTRÖM, K.; .; YE, LYE, L.; .; MALM, JMALM, J.; .; LI, Y.LLI, Y.L.; .; BLABLADH, L.GDH, L.G.; .; SLEPH, SLEPH, P.GP.G.; .; SMITH, SMITH, M.AM.A.; .; GEORGE, RGEORGE, R.; .; VENNVENNSTRÖM, BSTRÖM, B.; .; MOOKHTIAR, KMOOKHTIAR, K.; .; HORVATH, RHORVATH, R.; .; SPEELMAN, JSPEELMAN, J.; .; EGAEGAN, DN, D.; .; BAXTER, J.DBAXTER, J.D. Selective thyroid hormone receptor. Selective thyroid hormone receptor--beta beta activation: a strategy for reduction of weight, cholesterol, and lipoprotein (a) activation: a strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced with reduced cardiovascular liability. cardiovascular liability. Proc Natl Acad Sci U S A,Proc Natl Acad Sci U S A, v. 100, n. 17, p. 10067v. 100, n. 17, p. 10067--72, ago 2003.72, ago 2003. HEARSEHEARSE, D.J., D.J.; ; GARLICKGARLICK;; P. B.; P. B.; HUMPHREYHUMPHREY, S.M. , S.M. Ischemic contracture of the Ischemic contracture of the myocardium: Mechanisms and prevention. myocardium: Mechanisms and prevention. Am J Cardiol.Am J Cardiol., v. 39 n. 7, p. 986, v. 39 n. 7, p. 986--93, jun 1977.93, jun 1977. HEATHER, L.C HEATHER, L.C.; .; COLE, M..ACOLE, M..A; ; ATHERTON, H.JATHERTON, H.J.; .; COUMANS, W.ACOUMANS, W.A.; .; EVANS, R.DEVANS, R.D.; .; TYLER, D.JTYLER, D.J.; .; GLATZ, J.FGLATZ, J.F.; .; LUIKEN, J.JLUIKEN, J.J.; .; CLARKE, KCLARKE, K. . Adenosine monophosphateAdenosine monophosphate--activated protein kinase activation, substrate transporter translocation, and metabolism in the activated protein kinase activation, substrate transporter translocation, and metabolism in the contracting hyperthyroid rat heart. contracting hyperthyroid rat heart. EndocrinologyEndocrinology, v. 151, n. 1,, v. 151, n. 1, p:422p:422--31, 31, jan 2010.jan 2010. HEUSCH, GHEUSCH, G.; .; BOENGLER, BOENGLER, KK.; .; SCHULZ, RSCHULZ, R. Inhibition of mitochondrial permeability . Inhibition of mitochondrial permeability transition pore opening: the Holy Grail of cardioprotection.transition pore opening: the Holy Grail of cardioprotection. Basic Res CardiolBasic Res Cardiol , v. 105, v. 105, n. 2, , n. 2, p. 151p. 151--4 , mar 2010.4 , mar 2010. HOLLOWELL, J.G HOLLOWELL, J.G.; .; STAEHLING, N.WSTAEHLING, N.W.; .; FLANDERS, W.DFLANDERS, W.D.; .; HANNON, W.HHANNON, W.H.; .; GUNTER, GUNTER, E.WE.W.; .; SPENCER, C.ASPENCER, C.A.; .; BRAVERMAN, L.EBRAVERMAN, L.E. Serum TSH, T(4), and thyroid antibodies in the . Serum TSH, T(4), and thyroid antibodies in the United States population (19United States population (1988 to 1994): National Health and Nutrition Examination Survey 88 to 1994): National Health and Nutrition Examination Survey (NHANES III).(NHANES III).J Clin Endocrinol Metab.J Clin Endocrinol Metab. V. 87, n. 2, p.489V. 87, n. 2, p.489--99, fev 2002.99, fev 2002. HOLUBARSCH, C.; LUDEMANN, J.; WIESSNER, S.; RUF, T.; SCHULTEHOLUBARSCH, C.; LUDEMANN, J.; WIESSNER, S.; RUF, T.; SCHULTE--BAUKLOH, BAUKLOH, H.; SCHMIDTH.; SCHMIDT--SCHWEDA, S.SCHWEDA, S.; PIESKE, B.; POSIVAL, H.; JUST, H. Shortening versus ; PIESKE, B.; POSIVAL, H.; JUST, H. Shortening versus isometric contractions in isolated human failing and nonisometric contractions in isolated human failing and non--failing left ventricular myocardium: failing left ventricular myocardium: dependency of external work and force on muscle length, heart rate and inotropic stimulation. dependency of external work and force on muscle length, heart rate and inotropic stimulation. Cardiovasc. ReCardiovasc. Ress., v. 37, n. 1, p. 46., v. 37, n. 1, p. 46––57, jan 1998.57, jan 1998. 53 IERVASI G; MOLINARO S; LANDI P; TADDEI MC; GALLI E; MARIANI F; L'ABBATE IERVASI G; MOLINARO S; LANDI P; TADDEI MC; GALLI E; MARIANI F; L'ABBATE A; PINGITORE A. A; PINGITORE A. Association between increased mortality and mild thyroid dysfunction in Association between increased mortality and mild thyroid dysfunction in cardiac patients.cardiac patients. Arch. Intern. MedArch. Intern. Med., v. 167, n.14, p.1526., v. 167, n.14, p.1526--32, jul 2007.32, jul 2007. IORDANIDOU, A IORDANIDOU, A.; .; HADZOPOULOUHADZOPOULOU--CLADARAS, MCLADARAS, M.; .; LAZOU, ALAZOU, A. . NonNon--genomic effects genomic effects of thyroiof thyroid hormone in adult cardiac myocytes: relevance to gene expression and cell growth. d hormone in adult cardiac myocytes: relevance to gene expression and cell growth. Mol Cell Biochem.Mol Cell Biochem.,,v. 340,v. 340, n 1n 1--22, , p.291p.291--300, jul300, jul 2010.2010. IŞMAN, C.AIŞMAN, C.A.; .; YEĞEN, B.CYEĞEN, B.C.; .; ALICAN, IALICAN, I. . J. MethJ. Methimazoleimazole--induced hypothyroidism in rats induced hypothyroidism in rats ameliorates oxidative injury in experimental colitis. ameliorates oxidative injury in experimental colitis. J EndocrinolJ Endocrinol,, v.177, n.3, p. 471v.177, n.3, p. 471--6, Jun 6, Jun 2003.2003. JAFFET, R. R.F. Fisiología cardiac. JAFFET, R. R.F. Fisiología cardiac. In: Ciencias básicas. Disponível em: < In: Ciencias básicas. Disponível em: < http://www.medigraphic.com/pdfs/revmed/mdhttp://www.medigraphic.com/pdfs/revmed/md--2009/md093d.pdf2009/md093d.pdf > data de acesso 2de junho > data de acesso 2de junho de 2013.de 2013. KAHALY, G.J.; DILLMANN, W.H. Thyroid hormone action in the heart. KAHALY, G.J.; DILLMANN, W.H. Thyroid hormone action in the heart. Endocr RevEndocr Rev, v.26, n. , v.26, n. 5, p. 7045, p. 704--728, ago 2005.728, ago 2005. KANG, M KANG, M.; .; CHUNG, K.YCHUNG, K.Y.; .; WALKER, J.WWALKER, J.W. G. G--protein coupled receptor signaling in protein coupled receptor signaling in myocardium: not for the faint of heart. myocardium: not for the faint of heart. Physiology (Bethesda)Physiology (Bethesda), v. 22, p. 174, v. 22, p. 174--84, jun 2007.84, jun 2007. KASTURI, S KASTURI, S.; .; ISMAILISMAIL--BEIGI, FBEIGI, F. Effect of thyroid hormone on the distribution and activity . Effect of thyroid hormone on the distribution and activity of Na, Kof Na, K--ATPaseATPase in ventricular myocardium. in ventricular myocardium. Arch Biochem BiophysArch Biochem Biophys, v. 475, n. 2, p. 121, v. 475, n. 2, p. 121--7, 7, jul 2008.jul 2008. KIM, S.J.; IIZUKA, K.; KELLY, R.A.; GENG, Y.J.; BISHOP, S.P.; YANG, G.; KUDEJ, A.; KIM, S.J.; IIZUKA, K.; KELLY, R.A.; GENG, Y.J.; BISHOP, S.P.; YANG, G.; KUDEJ, A.; MCCONNELL, B.K.; SEIDMAN, C.E.; SEIDMAN, J.G.; VATNER, S.F. An alphaMCCONNELL, B.K.; SEIDMAN, C.E.; SEIDMAN, J.G.; VATNER, S.F. An alpha--cardiac cardiac myosin heavy chain gene mutation impaimyosin heavy chain gene mutation impairs contraction and relaxation function of cardiac rs contraction and relaxation function of cardiac myocytes. myocytes. Am. J. PhysiolAm. J. Physiol, n. 276, p.1780, n. 276, p.1780––1787, mai 1999.1787, mai 1999. KIMURA, E.T. Glândula Tireóide. KIMURA, E.T. Glândula Tireóide. In: MARGARIDA DE MELLO AYRES. In: MARGARIDA DE MELLO AYRES. FisiologiaFisiologia. São . São Paulo: Guanabara Koogan,. Paulo: Guanabara Koogan,. P. 991P. 991--1014, 2008.1014, 2008. KLEIN, I. Thyroid hormonKLEIN, I. Thyroid hormone and cardiac contractility. e and cardiac contractility. Am J CardiolAm J Cardiol.v.91, n. 11, p.1331.v.91, n. 11, p.1331--2, jun 2, jun 2003.2003. KLEIN, I KLEIN, I.; .; DANZI, SDANZI, S. Thyroid disease and the heart.. Thyroid disease and the heart.Circulation.Circulation., v. 116, n. 15, p. 1725, v. 116, n. 15, p. 1725--35, 35, out 2007.out 2007. KLEIN, I.; OJAMAA, K. Thyroid Hormo KLEIN, I.; OJAMAA, K. Thyroid Hormone and the Cardiovascular System. ne and the Cardiovascular System. N. Engl. J. MedN. Engl. J. Med., ., v. 344, p. 501v. 344, p. 501--509, fev 2001.509, fev 2001. KLEIN, I.; OJAMAA, K. Thyroid hormone KLEIN, I.; OJAMAA, K. Thyroid hormone –– targeting the heart. targeting the heart. EndocrinologyEndocrinology, v.142, n.1, , v.142, n.1, p. 11p. 11--12, Jan 2001.12, Jan 2001. KLIEVERIK, L.P KLIEVERIK, L.P.; .; COOMANS, C.PCOOMANS, C.P.; .; ENDERT, EENDERT, E.; .; SAUERWEIN, H.PSAUERWEIN, H.P.; .; HAVEKES, L.MHAVEKES, L.M.; .; VOSHOL, P.JVOSHOL, P.J.; .; RENSEN, P.CRENSEN, P.C.; .; ROMIJN, J.AROMIJN, J.A.; .; KALSBEEK, AKALSBEEK, A.; .; FLIERS, EFLIERS, E. Thyroid . Thyroid hormone effects on wholehormone effects on whole--body energy homeostabody energy homeostasis and tissuesis and tissue--specific fatty acid uptake in specific fatty acid uptake in 54 vivo. vivo.EndocrinologyEndocrinology, v.150, n.12, p. , v.150, n.12, p. 56395639--48, dez 2009.48, dez 2009. KOLOCASSIDES, K.GKOLOCASSIDES, K.G.; .; SEYMOUR, A.MSEYMOUR, A.M.; .; GALIÑANES, MGALIÑANES, M.; .; HEARSE, D.JHEARSE, D.J. Paradoxical . Paradoxical effect of ischemic preconditioning on ischemiceffect of ischemic preconditioning on ischemic contracture? NMR studies of energy contracture? NMR studies of energy metabolism and intracellular pH in the rat heart. metabolism and intracellular pH in the rat heart. J Mol Cell CardiolJ Mol Cell Cardiol., v. 28, n. 5, p. 1045., v. 28, n. 5, p. 1045--57, 57, maio 1996.maio 1996. KUTLUTURK, FKUTLUTURK, F.; .; YUCE, SYUCE, S.; .; TTASLIYURT, TASLIYURT, T.; .; YELKEN, B.MYELKEN, B.M.; .; AYAYTAN, PTAN, P.; .; OZTURK, BOZTURK, B.; .; YILMYILMAZ, AAZ, A. Changes in metabolic and cardiovascular risk factors before and after treatment . Changes in metabolic and cardiovascular risk factors before and after treatment in overt hypothyroidism. in overt hypothyroidism. Med Glas (Zenica)Med Glas (Zenica), v. 10, n. 2, p. , v. 10, n. 2, p. 348348--53, ago 2013.53, ago 2013. KUZMAN, J.AKUZMAN, J.A.; .; GERDES, A.MGERDES, A.M.; .; KOBAYASHI, SKOBAYASHI, S.; .; LIANG, QLIANG, Q. Thyroid hormone activates . Thyroid hormone activates Akt and prevents serum starvationAkt and prevents serum starvation--induced cell death in neonatal rat cardiomyocytes. induced cell death in neonatal rat cardiomyocytes. J Mol J Mol Cell Cardiol.Cell Cardiol. v. 39, n. 5, p. 841v. 39, n. 5, p. 841--4, nov 2005.4, nov 2005.bb KUZMAN, J.AKUZMAN, J.A.; .; VOGELSANG, K.AVOGELSANG, K.A.; .; THOMAS, T.ATHOMAS, T.A.; .; GERDES, A.MGERDES, A.M. L. L--Thyroxine Thyroxine activates Akt signalinactivates Akt signaling in the heart. g in the heart. J Mol Cell CardiolJ Mol Cell Cardiol, v. 39, n.2 , p. 251, v. 39, n.2 , p. 251--8, ago 2005.8, ago 2005.aa LIU, C.R LIU, C.R.; .; LI, L.YLI, L.Y.; .; SHI, FSHI, F.; .; ZANG, X.YZANG, X.Y.; .; LIU, Y.MLIU, Y.M.; .; SUN, YSUN, Y.; .; KAN, B.HKAN, B.H. Effects of hyper. Effects of hyper-- and hypothyroid on expression of thyroid hormone receptor mRNA in rat myocardium.and hypothyroid on expression of thyroid hormone receptor mRNA in rat myocardium. J. Endocrinol J. Endocrinol.., v.195, n. 3, p. 429, v.195, n. 3, p. 429--38, dez 2007.38, dez 2007. MA, X.LMA, X.L.; .; KUMAR, SKUMAR, S.; .; GAO, FGAO, F.; .; LOUDEN, C.SLOUDEN, C.S.; .; LOPEZ, B.LLOPEZ, B.L.; .; CHRISTOPHER, T.ACHRISTOPHER, T.A.; .; WANG, CWANG, C.; .; LEE, J.CLEE, J.C.; .; FEUERSTEIN, G.ZFEUERSTEIN, G.Z.; .; YUE, T.LYUE, T.L. . Inhibition of p38 mitogenInhibition of p38 mitogen--activated activated protein kprotein kinase decreases cardiomyocyte apoptosis and improves cardiac function after inase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. myocardial ischemia and reperfusion. Circulation.Circulation.,,v. 99, n. 13, p. 1685v. 99, n. 13, p. 1685--91, abril 1999.91, abril 1999. MAHAFFEY, K.W.; RAYA, T.E.; PENNOCK, G.D.; MORKIN, E.; GOLDMAN, S. Left MAHAFFEY, K.W.; RAYA, T.E.; PENNOCK, G.D.; MORKIN, E.; GOLDMAN, S. Left ventricular performance and remodeling iventricular performance and remodeling in rabbits after myocardial infarction. Effects of a n rabbits after myocardial infarction. Effects of a thyroid hormone analogue. thyroid hormone analogue. CirculationCirculation, v. 91, n. 3, p. 794, v. 91, n. 3, p. 794––801, fev 1995.801, fev 1995. MANNA, DMANNA, D.; .; ROY, GROY, G.,; .,; MUGESH, GMUGESH, G. Antithyroid Drugs . Antithyroid Drugs and Their Analogues: Synthesis, and Their Analogues: Synthesis, Structure, and Mechanism of Action. Structure, and Mechanism of Action. Acc. Chem. ResAcc. Chem. Res.., jul 2013., jul 2013. MOOLMAN, J.A. Thyroid hormone and the heart. MOOLMAN, J.A. Thyroid hormone and the heart. Cardiovasc. J. S. ACardiovasc. J. S. Afrfr., v.13, n. 4, p. 159., v.13, n. 4, p. 159––163, ago 2002163, ago 2002 MORENO, MMORENO, M.; .; LOMBARDI, ALOMBARDI, A.; .; LOMBARDI, PLOMBARDI, P.; .; GOGLIA, FGOGLIA, F.; .; LANNI, ALANNI, A. . Effect of 3,5Effect of 3,5--diiododiiodo--LL--thyronine on thyroid stimulating hormone and growth hormone serum levels in thyronine on thyroid stimulating hormone and growth hormone serum levels in hypothypothyroid rats. hyroid rats. Life Sci.Life Sci...,v. 62, n.26, p. 2369,v. 62, n.26, p. 2369--77, 1998.77, 1998. MOUROUZIS, IMOUROUZIS, I.; .; DIMOPOULOSDIMOPOULOS, A, A.; .; SARANTEAS, TSARANTEAS, T.; .; TSTSINARAKIS, NINARAKIS, N.; .; LIVADAROU, LIVADAROU, EE.; .; SPANOU, DSPANOU, D.; .; KOKKINOS, A,DKOKKINOS, A,D.; .; XINARIS, CXINARIS, C.; .; PANTOS, CPANTOS, C.; .; COKKINOS, D.VCOKKINOS, D.V. . Ischemic preconditioning fails to confer additional protection against ischemiaIschemic preconditioning fails to confer additional protection against ischemia--reperfusion reperfusion injury in the hypothyroid rat heart. injury in the hypothyroid rat heart. Physiol ResPhysiol Res, v. 58, n. 1, p. 29, v. 58, n. 1, p. 29--38 , 2009.38 , 2009. MURPHY, E; STEENBERGEN, C. Mechanisms Underlying Acute Protection MURPHY, E; STEENBERGEN, C. Mechanisms Underlying Acute Protection From Cardiac From Cardiac IschemiaIschemia--Reperfusion Injury. Reperfusion Injury. Physiol RevPhysiol Rev., v.88, n.2, p. 581., v.88, n.2, p. 581––609, abril 2008.609, abril 2008. 55 MURRAY, C.J MURRAY, C.J.; .; LOPEZ, A.DLOPEZ, A.D. Alternative projections of mortality and disability by cause . Alternative projections of mortality and disability by cause 19901990--2020: Global Burden of Disease Study. 2020: Global Burden of Disease Study. LancetLancet. , v. 349, n. 9064, p. 1498. , v. 349, n. 9064, p. 1498--504 , mai 504 , mai 1997.1997. NAM, S.M.; KNAM, S.M.; KIM, Y.N.; YOO, D.Y.; YI, S.S.; KIM, W.; HWANG, I.K.; SEONG, J.K.; IM, Y.N.; YOO, D.Y.; YI, S.S.; KIM, W.; HWANG, I.K.; SEONG, J.K.; YOON, Y.S. YOON, Y.S. Hypothyroid states mitigate the diabetesHypothyroid states mitigate the diabetes--induced reduction of calbindin Dinduced reduction of calbindin D--28k, 28k, calretinin, and parvalbumin immunoreacticalretinin, and parvalbumin immunoreactivity in type 2 diabetic rats.vity in type 2 diabetic rats. Neurochem ResNeurochem Res., v. 37, ., v. 37, n. 2, p.253n. 2, p.253--60, fev 2012.60, fev 2012. OJAMAA, K OJAMAA, K. Signaling mechanisms in thyroid hormone. Signaling mechanisms in thyroid hormone--induced carinduced cardiac hypertrophy. diac hypertrophy. Vascul Vascul PharmacolPharmacol, v. 52, n. 3, v. 52, n. 3--4, p. 1134, p. 113--9 , abril 2010.9 , abril 2010. OLIVARES, E.L OLIVARES, E.L.; .; MARASSI, M.PMARASSI, M.P.; .; FORTUNATO, R.SFORTUNATO, R.S.; .; DA SILVA, A.CDA SILVA, A.C.; .; COSTACOSTA--EE--SOUSA, R.HSOUSA, R.H.; .; ARAÚJO, I.GARAÚJO, I.G.; .; MATTOS, E.CMATTOS, E.C.; .; MASUDA, M.OMASUDA, M.O.; .; MULCAHEY, M.AMULCAHEY, M.A.; .; HUANG, S.AHUANG, S.A.; .; BIANCO, A.CBIANCO, A.C.; .; CARVALHO, D.PCARVALHO, D.P. . Thyroid function disturbance and type 3 Thyroid function disturbance and type 3 iodothyroniiodothyronine deiodinase induction after myocardial infarction in rats a time course study. ne deiodinase induction after myocardial infarction in rats a time course study. EndocrinologyEndocrinology.., v.148, n. 10, p. 4786, v.148, n. 10, p. 4786--92, out 200792, out 2007.. OREN, R.; DOTAN, I.; PAPA, M.; MARRAVI, Y.; AEED, H.; BARG, J.; OREN, R.; DOTAN, I.; PAPA, M.; MARRAVI, Y.; AEED, H.; BARG, J.; ZEIDEL, LZEIDEL, L.; .; BRUCK, RBRUCK, R.; .; HALPERN, ZHALPERN, Z. Inhibition of experimentally induced cirrhosis in rats by . Inhibition of experimentally induced cirrhosis in rats by hypothyroidism. hypothyroidism. HepatologyHepatology, v.24, n.2, p. 419, v.24, n.2, p. 419––23, ago 1996.23, ago 1996. OZTAY, F.; ERGIN, B.; USTUNOVA, S.; BALCI, H.; KAPUCU A.; CANER, M.; OZTAY, F.; ERGIN, B.; USTUNOVA, S.; BALCI, H.; KAPUCU A.; CANER, M.; DEMIRCI, C. Effects DEMIRCI, C. Effects of coenzyme Q10 on the heart ultrastructure and nitric oxide synthase of coenzyme Q10 on the heart ultrastructure and nitric oxide synthase during hyperthyroidism. during hyperthyroidism. Chin J. PhysiolChin J. Physiol, v. 50, n. 5, p. 217, v. 50, n. 5, p. 217--24, out 2007.24, out 2007. PANTOS, C.IPANTOS, C.I.; .; MALLIOPOULOU, V.AMALLIOPOULOU, V.A.; .; MOUROUZIS, I.SMOUROUZIS, I.S.; .; KARAMANOLI, E.PKARAMANOLI, E.P.; .; PAIZIS, I.APAIZIS, I.A.; .; STEIMBERG, NSTEIMBERG, N.; .; VARONOS, D.DVARONOS, D.D.; .; COKKINOS, D.VCOKKINOS, D.V. Long. Long--term thyroxine term thyroxine administration protects the heart in a pattern similar tadministration protects the heart in a pattern similar to ischemic preconditioning.o ischemic preconditioning.ThyroidThyroid, v. , v. 12, n. 412, n. 4 , p. 325, p. 325--9, abril 20029, abril 2002.. PANTOS, C PANTOS, C.; .; MALLIOPOULOU, VMALLIOPOULOU, V.; .; MOUROUZIS, IMOUROUZIS, I.; .; SFAKIANOUDIS, KSFAKIANOUDIS, K.; .; TZEIS, STZEIS, S.; .; DOUMBA , PDOUMBA , P.; .; XINARIS, CXINARIS, C.; .; COKKINOS, A.DCOKKINOS, A.D.; .; CARAGEORGIOU, HCARAGEORGIOU, H.; .; VARONOS, VARONOS, D.DD.D.; .; COKKINOS, D.VCOKKINOS, D.V. . PropylthiouracilPropylthiouracil--induced hypotinduced hypothyroidism is associated with hyroidism is associated with increased tolerance of the isolated rat heart to ischaemiaincreased tolerance of the isolated rat heart to ischaemia--reperfusion. reperfusion. J EndocrinolJ Endocrinol, v. 178, n.3 , v. 178, n.3 p. 427p. 427--35, set 2003.35, set 2003. PANTOS, C PANTOS, C.; .; MOUROUZIS, IMOUROUZIS, I.; .; COKKINOS, D.VCOKKINOS, D.V. . Thyroid hormone as a therapeutic option Thyroid hormone as a therapeutic option for treating ischaemic heart disease: from early reperfusion to late remodelling. for treating ischaemic heart disease: from early reperfusion to late remodelling. VasculVascul PharmacolPharmacol, v. 52, n. 3, v. 52, n. 3--4,p. 1574,p. 157--65, mar65, mar--abril 2010.abril 2010. PPANTOSANTOS, C.; , C.; MOUROUZISMOUROUZIS, I.; , I.; DELBRUYÈREDELBRUYÈREBB, M.; , M.; MALLIOPOULOUMALLIOPOULOU, V.; , V.; TZEISTZEIS, S.; , S.; COKKINOSCOKKINOS, D. D.; , D. D.; NIKITASNIKITAS, N. ; , N. ; CARAGEORGIOUCARAGEORGIOU, H.; , H.; VARONOSVARONOS, D.; , D.; COKKINOSCOKKINOS, , D.; D.; NISATONISATO, D. Effects of dronedarone and amiodarone on plasma thyroid hormones and on , D. Effects of dronedarone and amiodarone on plasma thyroid hormones and on the basal and postischemic performance of the isolated rat heart.the basal and postischemic performance of the isolated rat heart. Eur J Pharmacol.Eur J Pharmacol., v. 4, v. 444, n. 44, n. 3, p. 1913, p. 191--6, mai 2002.6, mai 2002. PANTOS, C.; MOUROUZIS, I.; MARKAKIS, K.; DIMOPOULOS, A.; XINARIS, C.; PANTOS, C.; MOUROUZIS, I.; MARKAKIS, K.; DIMOPOULOS, A.; XINARIS, C.; KOKKINOS, A.D.; PANAGIOTOU, M.; COKKINOS, D.V. Thyroid hormone attenuates KOKKINOS, A.D.; PANAGIOTOU, M.; COKKINOS, D.V. Thyroid hormone attenuates 56 cardiac remodeling and improves hemodynamics early after acute myocardial infarctcardiac remodeling and improves hemodynamics early after acute myocardial infarction in ion in rats. rats. Eur. J. Cardiothorac. SurgEur. J. Cardiothorac. Surg., v. 32, n.2, p. 333., v. 32, n.2, p. 333––339, ago 2007.339, ago 2007. PANTOS, C.I PANTOS, C.I.; .; MOUROUZIS, I.SMOUROUZIS, I.S.; .; TZEIS, S.MTZEIS, S.M.; .; MALLIOPOULOU, VMALLIOPOULOU, V.; .; COKKINOS, COKKINOS, D.DD.D.; .; ASIMACOPOULOS, PASIMACOPOULOS, P.; .; CARAGEORGIOU, H.CCARAGEORGIOU, H.C.; .; VARONOS, D.DVARONOS, D.D.; .; COKKINOS, COKKINOS, D.VD.V. . PropraPropranolol diminishes cardiac hypertrophy but does not abolish acceleration of the nolol diminishes cardiac hypertrophy but does not abolish acceleration of the ischemic contracture in hyperthyroid hearts. ischemic contracture in hyperthyroid hearts. J Cardiovasc Pharmacol, J Cardiovasc Pharmacol, v. 36v. 36, n. 3 p. 384, n. 3 p. 384--9, set 9, set 2000.2000. PATTON, K. KPATTON, K. K.; .; LEVY, MLEVY, M.; .; VISWANATHAN, MVISWANATHAN, M. Atrial lead dysfunction: an unusual . Atrial lead dysfunction: an unusual feature of hypothyroidism. feature of hypothyroidism. Pacing Clin ElectrophysiolPacing Clin Electrophysiol, v. 31, n. 12, p.1650, v. 31, n. 12, p.1650--2, dec 2008.2, dec 2008. REED, T.DREED, T.D.; .; BABU, G.JBABU, G.J.; .; JI, YJI, Y.; .; ZILBERMAN, AZILBERMAN, A.; .; VER HEYEN, MVER HEYEN, M.; .; WUYTACK, FWUYTACK, F.; .; PERIASAMY. MPERIASAMY. M. The expression of SR calcium transport . The expression of SR calcium transport ATPaseATPase and the and the NaNa++/Ca/Ca2+2+Exchanger are antithetically regulated during mouse cardiac development and in Exchanger are antithetically regulated during mouse cardiac development and in Hypo/hyperthyroidism. Hypo/hyperthyroidism. J. Mol. Cell. CardiolJ. Mol. Cell. Cardiol.., v. 3, v. 32, n. 3, p.4532, n. 3, p.453--64, mar 2000.64, mar 2000. REGNIER, MREGNIER, M.; .; MARTIN, HMARTIN, H.; .; BARSOTTI, R.JBARSOTTI, R.J.; .; RIVERA, A.JRIVERA, A.J.; .; MARTYN, D.AMARTYN, D.A.; .; CLEMMENS, ECLEMMENS, E. Cross. Cross--bridge versus thin filament contributions to the level and rate of force bridge versus thin filament contributions to the level and rate of force development in cardiac muscle. development in cardiac muscle. Biophys, J.Biophys, J. ,v. 87, n. 3, p.1815,v. 87, n. 3, p.1815--24, set 2004.24, set 2004. ROBERTS, B.N ROBERTS, B.N.; .; CHRISTINI, D.JCHRISTINI, D.J. NHE inhibition does not improve Na. NHE inhibition does not improve Na++ or Ca or Ca 2+2+ overload overload during reperfusion: using modeling to illuminate the mechanisms underlying during reperfusion: using modeling to illuminate the mechanisms underlying a therapeutic a therapeutic failure. failure. PLoS Comput BiolPLoS Comput Biol.., v. 7, n. 10, out2011., v. 7, n. 10, out2011. ROBIN, E ROBIN, E.; .; GUZY, R.DGUZY, R.D.; .; LOOLOOR, GR, G.; .; IWASE, HIWASE, H.; .; WAYPA, G.BWAYPA, G.B.; .; MARKS, J.DMARKS, J.D.; .; HOEK, HOEK, T.LT.L.; .; SCHUMACKER, P.TSCHUMACKER, P.T. . Oxidant stress during simulated ischemia primes cardiomyocytes for cell death during reperfusion. J Biol Chem.J Biol Chem., v. 282, n. 26, jun 2007., v. 282, n. 26, jun 2007. RODRÍGUEZRODRÍGUEZ--GÓMEZ IGÓMEZ I; ; CRUZ, ACRUZ, A.; .; MORENO, J.MMORENO, J.M.; .; SOLER, ASOLER, A.; .; OSUNA, AOSUNA, A.; .; VARGAS, FVARGAS, F. . Clofibrate prevents and reverses the hemodynamic mClofibrate prevents and reverses the hemodynamic manifestations of anifestations of hyperthyroidism in rats. hyperthyroidism in rats. Am J Hypertens., Am J Hypertens., v. 21, n. 3, p. 341v. 21, n. 3, p. 341--7 mar 2008.7 mar 2008. ROSEN, M.D ROSEN, M.D.; .; PRIVALSKY, M.LPRIVALSKY, M.L. Thyroid hormone receptor mutations in cancer and . Thyroid hormone receptor mutations in cancer and resistance to thyroid hormone: perspective and prognosis. resistance to thyroid hormone: perspective and prognosis. J Thyroid ResJ Thyroid Res.., jun 2011., jun 2011. RYBIN, V.; STEINBERG, S.F. Thyroid hormone represses protein kinase C isoform RYBIN, V.; STEINBERG, S.F. Thyroid hormone represses protein kinase C isoform expressiexpression and activity in rat cardiac myocytes. on and activity in rat cardiac myocytes. Circ. ResCirc. Res., v. 79, n. 3, p. 388., v. 79, n. 3, p. 388––398, set 1996.398, set 1996. SALVATORE, D.; LOW, S.C.; BERRY, M.; MAIA, A.L.; HARNEY, J.W.; CROTEAU, W.; SALVATORE, D.; LOW, S.C.; BERRY, M.; MAIA, A.L.; HARNEY, J.W.; CROTEAU, W.; ST. GERMAIN, D.L.; LARSEN, P.R. Type 3 lodothyronine deiodinase: cloning, in vitro ST. GERMAIN, D.L.; LARSEN, P.R. Type 3 lodothyronine deiodinase: cloning, in vitro expressiexpression, and functional analysis of the placental selenoenzyme. on, and functional analysis of the placental selenoenzyme. J Clin InvestJ Clin Invest. , v. 96, n. 5, . , v. 96, n. 5, p. 2421p. 2421––2430, nov, 1996.2430, nov, 1996. SANTOS, R.ASANTOS, R.A.; .; BARRETOBARRETO--CHAVES, M.LCHAVES, M.L. . Cardiac angiotensin II type I and type II Cardiac angiotensin II type I and type II receptors are increased in rats submitted to experimental hypothyroidism. receptors are increased in rats submitted to experimental hypothyroidism. J PhysiolJ Physiol.., v. 583, , v. 583, pt 1, p. 21pt 1, p. 2133--23, ago 2007.23, ago 2007. SCHRIEWER, J.MSCHRIEWER, J.M.; .; PEEK, C.BPEEK, C.B.; .; BASS, JBASS, J.; .; SCHUMACSCHUMACKER, P.TKER, P.T. Ros. Ros--mediated PARP mediated PARP 57 activity undermines mitochondrial function after permeability transition pore opening during activity undermines mitochondrial function after permeability transition pore opening during myocardial ischemiamyocardial ischemia--reperfusion. reperfusion. J Am Heart AssocJ Am Heart Assoc.. , v. 2, n.2, abril 2013., v. 2, n.2, abril 2013. SHAHEEN, MSHAHEEN, M.; .; CHEEMA, YCHEEMA, Y.; .; SHAHBAZ, A.USHAHBAZ, A.U.; .; BHATTACHARYA, S.KBHATTACHARYA, S.K.; .; WEBER, K.TWEBER, K.T. . Intracellular calcium overloading and oxidative stress in cardiomyocyte necrosis via a Intracellular calcium overloading and oxidative stress in cardiomyocyte necrosis via a mitochondriocentric signalmitochondriocentric signal--transducertransducer--effector pathway. effector pathway. Exp Clin CardiolExp Clin Cardiol, v. 16, n. 4, p. 109, v. 16, n. 4, p. 109--15, 20115, 2011.1. SHENOY, R SHENOY, R.; .; KLEIN, IKLEIN, I.; .; OJAMAA, KOJAMAA, K. Differential regulation of SR calcium transporters by . Differential regulation of SR calcium transporters by thyroid hormone in rat atria and ventricles. thyroid hormone in rat atria and ventricles. Am J Physiol Heart Circ Physiol.Am J Physiol Heart Circ Physiol., v. 281, n. 4, , v. 281, n. 4, p.1690p.1690--6. , out 2001.6. , out 2001. SILVA, F.GSILVA, F.G.; .; GIANNOCCO, GGIANNOCCO, G.; .; SANTOS, M.FSANTOS, M.F.; .; NUNES, M.TNUNES, M.T. . Thyroid hormone induction Thyroid hormone induction of actin polymerization in somatotrophs of hypothyroid rats: potential reof actin polymerization in somatotrophs of hypothyroid rats: potential repercussions in growth percussions in growth hormone synthesis and secretion. hormone synthesis and secretion. Endocrinology.Endocrinology., v. 147, n. 12, p. 5777, v. 147, n. 12, p. 5777--85, dez 2006.85, dez 2006. SIMPSON, P.C.; CAMACHO, S.A. Thyroid hormone improves function and SIMPSON, P.C.; CAMACHO, S.A. Thyroid hormone improves function and Ca Ca 2+2+ handling handling in pressure overload hypertrophy. Association with increased sarcoplasmic reticulum Cain pressure overload hypertrophy. Association with increased sarcoplasmic reticulum Ca2+2+ --ATPaseATPase and alphaand alpha--myosin heavy chain in rat hearts. myosin heavy chain in rat hearts. J. Clin. InvestJ. Clin. Invest, v. 100, n. 7, p. 1742, v. 100, n. 7, p. 1742––9, out 9, out 1997.1997. SONG, L.J SONG, L.J.; .; WANG, G.LWANG, G.L.; .; LIU, JLIU, J.; .; QIU, Q.YQIU, Q.Y.; .; OU, J.HOU, J.H.; .; GUAN, Y.YGUAN, Y.Y. Cellular mechanisms of . Cellular mechanisms of reduced sarcoplasmic reticulum Careduced sarcoplasmic reticulum Ca2+2+ content in Lcontent in L--thyroxin induced rat ventricular thyroxin induced rat ventricular hypertrophy. hypertrophy. Acta Pharmacol SinActa Pharmacol Sin.., v. 29, n. 4, p. 430, v. 29, n. 4, p. 430--6, abril 2008.6, abril 2008. SOUKUP, TSOUKUP, T.; .; ZACHAROVÁ, ZACHAROVÁ, GG.; .; SMERDU, VSMERDU, V.; .; JIRMANJIRMANOVÁ, IOVÁ, I. . Body, heart, thyroid gland Body, heart, thyroid gland and skeletal muscle weight changes in rats with altered thyroid status. and skeletal muscle weight changes in rats with altered thyroid status. PPhysiol Res.hysiol Res., v. 50, n.6, , v. 50, n.6, p.619p.619--26, 2001.26, 2001. SOUZA, M. O. Transportadores de Membrana. In: MARGARIDA DE MELLO AYRES. SOUZA, M. O. Transportadores de Membrana. In: MARGARIDA DE MELLO AYRES. FisiologiaFisiologia. São Paulo: Guanabara Koogan,. P. 167. São Paulo: Guanabara Koogan,. P. 167--181. 181. STANBURY, J.B STANBURY, J.B.; .; ERMANS, A.EERMANS, A.E.; .; BOURDOUX, PBOURDOUX, P.; .; TODD, CTODD, C.; .; OKEN, EOKEN, E.; .; TONGLET, RTONGLET, R.; .; VIDOR, GVIDOR, G.; .; BRAVERMAN, L.EBRAVERMAN, L.E.; .; MEDEIROSMEDEIROS--NETO, GNETO, G. . IodineIodine--induced hyperthyroidism: induced hyperthyroidism: occurrence and epidemiology., occurrence and epidemiology., ThyroidThyroid v. 8, n. 1, p. 83v. 8, n. 1, p. 83--100, jan 1998.100, jan 1998. SKRZYPIEC SKRZYPIEC--SPRING, MSPRING, M.; .; GROTTHUS, BGROTTHUS, B.; .; SZELAG, ASZELAG, A.; .; SCHULZ, RSCHULZ, R. Isolated heart . Isolated heart perfusion acperfusion according to Langendorffcording to Langendorff--still viable in the new millennium. still viable in the new millennium. J Pharmacol Toxicol J Pharmacol Toxicol Methods.Methods., v. 55, n.2, p.113, v. 55, n.2, p.113--26, Mar 2007.26, Mar 2007. SUN, Z.Q.; OJAM SUN, Z.Q.; OJAMAA, K.; COETZEE, W.A.; ARTMAN, M.; KLEIN, I .AA, K.; COETZEE, W.A.; ARTMAN, M.; KLEIN, I .Effects of thyroid Effects of thyroid hormone on action potential and repolarizing currents in rat ventricular myocytes.hormone on action potential and repolarizing currents in rat ventricular myocytes. Am. J. Am. J. Physiol. EndocrinolPhysiol. Endocrinol. . MetabMetab., v. 278, n.2, ., v. 278, n.2, p.302p.302--7, fev 2000.7, fev 2000. SWAROOP, A.; RAMASARMA, T. Heat exposure and hypothyroid conditions decrease SWAROOP, A.; RAMASARMA, T. Heat exposure and hypothyroid conditions decrease hydrogen peroxide generation in liver mitochondria. hydrogen peroxide generation in liver mitochondria. Biochemical JournalBiochemical Journal, v. 226, n. 2, p. , v. 226, n. 2, p. 403403––408, mar 1985.408, mar 1985. TAKANO, A.PTAKANO, A.P.; .; DINIZ, G.PDINIZ, G.P.; .; BARRETOBARRETO--CHAVES, M.LCHAVES, M.L. AMPK signaling pathway is . AMPK signaling pathway is 58 rapidly activated by T3 and regulates the cardiomyocyte growth.rapidly activated by T3 and regulates the cardiomyocyte growth. Mol Cell EndocrinolMol Cell Endocrinol, v. 376, , v. 376, n. 1n. 1--2, p. 432, p. 43--50, ago 2013.50, ago 2013. TANG, YD; KUZMATANG, YD; KUZMAN JA; SAID S.; ANDERSON BE; WANG X; GERDES A.M. Low N JA; SAID S.; ANDERSON BE; WANG X; GERDES A.M. Low thyroid function leads to cardiac atrophy with chamber dilatation, impaired myocardial blood thyroid function leads to cardiac atrophy with chamber dilatation, impaired myocardial blood flow, loss of arterioles, and severe systolic dysfunction. flow, loss of arterioles, and severe systolic dysfunction. CirculationCirculation, v.112, n.20, p.3122, v.112, n.20, p.3122––3130, nov 2005.3130, nov 2005. TOTOMANEK, R.J.; ZIMMERMAN, M.B.; SUVARNA, P.R.; MORKIN, E.; PENNOCK, G.D.; MANEK, R.J.; ZIMMERMAN, M.B.; SUVARNA, P.R.; MORKIN, E.; PENNOCK, G.D.; GOLDMAN, S. A thyroid hormone analog stimulates angiogenesis in the postGOLDMAN, S. A thyroid hormone analog stimulates angiogenesis in the post--infarcted rat infarcted rat heart.heart. J Mol Cell Cardiol, J Mol Cell Cardiol, v. 30, n.5, p. 923v. 30, n.5, p. 923––932, maio 1998.932, maio 1998. TRIBULOVA, NTRIBULOVA, N.; .; KNEZL, VKNEZL, V.; .; SHAINBERG, ASHAINBERG, A.; .; SEKI, SSEKI, S.; .; SOUKUP, TSOUKUP, T. Thyroid hormones . Thyroid hormones and cardiac arrhythmias. and cardiac arrhythmias. Vascul. PharmacolVascul. Pharmacol.., v.52, n. 3, v.52, n. 3--4, p.1024, p.102--12, mar 2010.12, mar 2010. TURER, A.T.; HILL, J.A. Pathogenesis of myocardial ischemia TURER, A.T.; HILL, J.A. Pathogenesis of myocardial ischemia--reperfusion injury and reperfusion injury and rationale for Therapy. rationale for Therapy. Am J cardiol.,Am J cardiol., v. 106, v. 106, n. 3, p.360n. 3, p.360––8, ago 2010.8, ago 2010. UETA, UETA, C.B.; OSKOUEI, B.N.;C.B.; OSKOUEI, B.N.; OLIVARES,OLIVARES, E.L.; PINTO, J.R.; CORREA, M.M.; SIMOVIC, E.L.; PINTO, J.R.; CORREA, M.M.; SIMOVIC, G.; SIMONIDES, W,S,; HARE, J.M.; BIANCO, A.C. G.; SIMONIDES, W,S,; HARE, J.M.; BIANCO, A.C. Absence of myocardial thyroid Absence of myocardial thyroid hormone inactivahormone inactivating deiodinase results in restrictive cardiomyopathy in mice.ting deiodinase results in restrictive cardiomyopathy in mice. Mol Mol Endocrinol,Endocrinol, v. 26, n. 5, p. 809v. 26, n. 5, p. 809--18, maio 2012.18, maio 2012. VALKO, M VALKO, M.; .; LEIBFRITZ, DLEIBFRITZ, D.; .; MONCOL, JMONCOL, J.; .; CRONIN, M.TCRONIN, M.T.; .; MAZUR, MMAZUR, M.; .; TELSER, JTELSER, J. . Free radicals and antioxidants in normal physiological functions and human disease. Free radicals and antioxidants in normal physiological functions and human disease. Int J Int J Biochem Cell BiolBiochem Cell Biol.,., v. 39, n. 1, p. 44v. 39, n. 1, p. 44--84, 2007.84, 2007. VASSALO, D. V.; OLIVEIRA, E.M; STEFANON, I. Contratilidade Miocárdica. In: VASSALO, D. V.; OLIVEIRA, E.M; STEFANON, I. Contratilidade Miocárdica. In: MARGARIDA DE MELLO AYRES. MARGARIDA DE MELLO AYRES. FisiologiaFisiologia. São Paulo: Guanabara Koog. São Paulo: Guanabara Koogan, p.435an, p.435--469., 469., 2008.2008. VIVALDI, M. T; KLONER, R. A; SCHOEN, F. J. VIVALDI, M. T; KLONER, R. A; SCHOEN, F. J. Triphenyltetrazolium staining of Triphenyltetrazolium staining of irreversible ischemic injury following coronary artery occlusion in rats.irreversible ischemic injury following coronary artery occlusion in rats. Am. J. PatholAm. J. Pathol.., v.121, , v.121, n.3, p. 522n.3, p. 522––530, dez 1985.530, dez 1985. WALKER, M.J WALKER, M.J.; .; CURTIS, M.JCURTIS, M.J.; .; HEARSE, D.JHEARSE, D.J.; .; CAMPBELL, R.WCAMPBELL, R.W.; .; JANSE, M.JJANSE, M.J.; .; YELLON, D.MYELLON, D.M.; .; COBBE, S.MCOBBE, S.M.; .; COKER, S.JCOKER, S.J.; .; HARNESS, J.BHARNESS, J.B.; .; HARRON, D.WHARRON, D.W., ., HIGGINS, A. J.; JULIAN, D. J.; LAB, M. J.; MANNING, A. S.; NORTHOVER, B. J.; HIGGINS, A. J.; JULIAN, D. J.; LAB, M. J.; MANNING, A. S.; NORTHOVER, B. J.; PARRATT, J. R.; RIEMERSMA, R. A.; RIVA, E.; RUSSELL, D.C.; SHERIDAN, D. J.; PARRATT, J. R.; RIEMERSMA, R. A.; RIVA, E.; RUSSELL, D.C.; SHERIDAN, D. J.; WINSLOW, E.; WOODWARD, B. The Lambeth Conventions: guidelines for the study WINSLOW, E.; WOODWARD, B. The Lambeth Conventions: guidelines for the study of of arrhythmias in ischaemia infarction, and reperfusion. arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc ResCardiovasc Res , v. 22, n. 7, p. 447, v. 22, n. 7, p. 447--55, 55, jul 1988.jul 1988. WALSH, J.PWALSH, J.P.; .; BREMNER, A.PBREMNER, A.P.; .; BULSARA, M.KBULSARA, M.K.; .; O'LEARY, PO'LEARY, P.; .; LEEDMAN, P.JLEEDMAN, P.J.; .; FEDDEMA, PFEDDEMA, P.; .; MICHELANGELI, VMICHELANGELI, V. Subcl. Subclinical thyroid dysfunction as a risk factor for inical thyroid dysfunction as a risk factor for cardiovascular disease. cardiovascular disease. Arch Intern Med.Arch Intern Med. , v.165, n. 21, p. 2467, v.165, n. 21, p. 2467--72, nov 2005.72, nov 2005. WANG, B.; OUYANG, J.; XIA. Z. WANG, B.; OUYANG, J.; XIA. Z. Effects of triiodoEffects of triiodo--thyronine on angiotensinthyronine on angiotensin--induced induced cardiomyocyte hypertrophy: reversal of increased βcardiomyocyte hypertrophy: reversal of increased β--myosin heavy chain gene expression. myosin heavy chain gene expression. 59 Canadian Journal of Physiology and Pharmacology Canadian Journal of Physiology and Pharmacology, v. 84, n. 8, v. 84, n. 8--9, p. 9359, p. 935--941 , out 2006.941 , out 2006. WANG, Y.Y.; JIAO, B.; GUO, W.G.; CHE, H.L.; YU, Z.B. WANG, Y.Y.; JIAO, B.; GUO, W.G.; CHE, H.L.; YU, Z.B. Excessive thyroxine enhances Excessive thyroxine enhances susceptibility to apoptosis and decreases contractility of cardiomyocytes.susceptibility to apoptosis and decreases contractility of cardiomyocytes. Mol Cell Mol Cell Endocrinol,Endocrinol, v. 14, n. 320, (1v. 14, n. 320, (1--2), p.672), p.67--75, Fev 2010.75, Fev 2010. WATANABE, H.; MA, M.; WASHIZUKA, T.; KOMURA, S.; YOSHIDA, T.; HOSAKA, Y.;WATANABE, H.; MA, M.; WASHIZUKA, T.; KOMURA, S.; YOSHIDA, T.; HOSAKA, Y.; HATADA, K.; CHINUSHI, M.; YAMAMOTO, T.; WATANABE, K.; AIZAWA, Y. Thyroid HATADA, K.; CHINUSHI, M.; YAMAMOTO, T.; WATANABE, K.; AIZAWA, Y. Thyroid hormone regulates mRNA expression and currents of ion channels in rat atrium. hormone regulates mRNA expression and currents of ion channels in rat atrium. Biochem Biochem Biophys Res CommunBiophys Res Commun, v. 308, n. 3, p. 439, v. 308, n. 3, p. 439––444, ago 2003.444, ago 2003. WHITTINGTON, H. J.; BABU, G.G.; MOCAN WHITTINGTON, H. J.; BABU, G.G.; MOCANU, M. M.; YELLON, D. M.; HAUSENLOY, U, M. M.; YELLON, D. M.; HAUSENLOY, D. J. D. J. The Diabetic Heart: Too Sweet for Its Own Good?The Diabetic Heart: Too Sweet for Its Own Good?Cardiol Res PractCardiol Res Pract. , fev 2012.. , fev 2012. WOEBER, K.A. Thyrotoxicosis and the heart. WOEBER, K.A. Thyrotoxicosis and the heart. N. Engl. J. MedN. Engl. J. Med., v. 3., v. 327, n. 2, p. 9427, n. 2, p. 94––98, jul 98, jul 1992.1992. WOJCICKA, A WOJCICKA, A.; .; BASSETT, J.HBASSETT, J.H.;.;WILLIAMS, G.RWILLIAMS, G.R. Mechanisms of action of thyroid . Mechanisms of action of thyroid hormones in the skeleton. hormones in the skeleton. Biochim Biophys Acta.Biochim Biophys Acta.,,v.1830, n.7, p.:3979v.1830, n.7, p.:3979--86, jul 2013.86, jul 2013. WU, SWU, S.; .; TAN, GTAN, G.; .; DONG, XDONG, X.; .; ZHU, ZZHU, Z.; .; LI, WLI, W.; .; LOU, ZLOU, Z.; .; CHAI, YCHAI, Y. Metabolic profiling . Metabolic profiling provides a system understanding of provides a system understanding of hypothyroidismhypothyroidism inin ratsrats and its and its application. application. PLoS One, PLoS One, v. v. 8, n. 28, n. 2.. , fev 2013., fev 2013. WU, Y.; PENG, J.; CAMPBEWU, Y.; PENG, J.; CAMPBELL, K.B.; LABEIT, S.; GRANZIER, H. Hypothyroidism leads LL, K.B.; LABEIT, S.; GRANZIER, H. Hypothyroidism leads to increased collagento increased collagen--based stiffness and rebased stiffness and re--expression of large cardiac titin isoforms with expression of large cardiac titin isoforms with high compliance. high compliance. J Molec Cell CardiolJ Molec Cell Cardiol, v. 42, n. 1, p. 186, v. 42, n. 1, p. 186--95, jan 2007.95, jan 2007. XIA, H.J XIA, H.J.; .; DAI, D.ZDAI, D.Z.; .; DAI, YDAI, Y. Up. Up--regulated inflammatory factors endothelin, NFkappaB, regulated inflammatory factors endothelin, NFkappaB, TNFalpha and iNOS involved in exaggerated cardiac arrhythmias in lTNFalpha and iNOS involved in exaggerated cardiac arrhythmias in l--thyroxinethyroxine--induced induced cardiomyopathy are suppressed by darusentacardiomyopathy are suppressed by darusentan in rats. n in rats. Life Sci.Life Sci., v. 79, n. 19, p.1812, v. 79, n. 19, p.1812--9, out 9, out 2006.2006. YAMADAYAMADA--OKABE, T.; SATOH, Y.; YAMADAOKABE, T.; SATOH, Y.; YAMADA--OKABE, H. Thyroid hormone induces the OKABE, H. Thyroid hormone induces the expression of 4expression of 4--1BB and activation of caspases in a thyroid hormone receptor1BB and activation of caspases in a thyroid hormone receptor––dependent dependent manner. manner. Eur. J. Biochem.Eur. J. Biochem., v. 270, n. 1, v. 270, n. 14, p. 30644, p. 3064--3073, jul 2003.3073, jul 2003. YETGIN, T YETGIN, T.; .; MANINTVELD, O.CMANINTVELD, O.C.; .; DUNCKER, D.JDUNCKER, D.J.;.;VAN DER GIESSEN, W.JVAN DER GIESSEN, W.J. . Postconditioning against ischaemiaPostconditioning against ischaemia--reperfusion injury: ready for wide application in patients? reperfusion injury: ready for wide application in patients? Neth Heart JNeth Heart J.., v. 18, n. 7, v. 18, n. 7--8, p. 3898, p. 389--92 , ago 2010.92 , ago 2010. YUE, L.; FENG, J.; GASPO, R.; LI, G.R.; WANG, Z.; NATTEL, S. Ionic remodeliYUE, L.; FENG, J.; GASPO, R.; LI, G.R.; WANG, Z.; NATTEL, S. Ionic remodeling ng underlying action potential changes in a canine model of atrial fibrillation. underlying action potential changes in a canine model of atrial fibrillation. Circ ResCirc Res, v. 81, , v. 81, n.4, p.512n.4, p.512––525, out 1997.525, out 1997. ZHANG, L.; PARRATT, J.R.; BEASTALL, G.H.; PYNE, N.J.; FURMAN, B.L. ZHANG, L.; PARRATT, J.R.; BEASTALL, G.H.; PYNE, N.J.; FURMAN, B.L. Streptozotocin diabetes protects against arrhythmias in rat isolStreptozotocin diabetes protects against arrhythmias in rat isolated hearts: role of ated hearts: role of hypothyroidsm. hypothyroidsm. Eur. J. PharmacolEur. J. Pharmacol. , v. 435, n. 2. , v. 435, n. 2--3, p. 2693, p. 269--276, jan 2002.276, jan 2002. 60 ZIVKOVIC, V ZIVKOVIC, V.; .; DJURIC, DDJURIC, D.; .; TURJACANINTURJACANIN--PANTELIC, DPANTELIC, D.; .; MARINKOVIC, ZMARINKOVIC, Z.; .; STEFANOVIC, DSTEFANOVIC, D.; .; SREJOVIC, ISREJOVIC, I.; .; JAKOVLJEVICJAKOVLJEVIC, V, V. The effects of cyclooxygenase and . The effects of cyclooxygenase and nitric oxide synthase inhibition on cardiodynamic parameters and coronary flow in isolated rat nitric oxide synthase inhibition on cardiodynamic parameters and coronary flow in isolated rat hearts. hearts. Exp Clin CaExp Clin Cardiolrdiol.., v. 18, n. 2, p. 102, v. 18, n. 2, p. 102--110, 2013.110, 2013. ZOROV, D.BZOROV, D.B.; .; JUHASZOVA, MJUHASZOVA, M.; .; SOLLOTT, S.JSOLLOTT, S.J. . Mitochondrial ROSMitochondrial ROS--induced ROS release: induced ROS release: an update and review. an update and review. Biochim Biophys ActaBiochim Biophys Acta.., v. 1757, n. 5, v. 1757, n. 5--6, p. 5096, p. 509--17, mai 2006.17, mai 2006. ZWEIER, J.L ZWEIER, J.L.; .; TALUKDER, M.ATALUKDER, M.A. The role of oxidants and free radicals in reperfusion . The role of oxidants and free radicals in reperfusion injury. injury. CardiCardiovasc Resovasc Res., v. 70, n. 2, p. 181., v. 70, n. 2, p. 181--90, mai 2006.90, mai 2006. | por |
dc.subject.cnpq | Medicina Veterinária | por |
dc.thumbnail.url | https://tede.ufrrj.br/retrieve/14266/2013%20-%20Ana%20Paula%20Antunes%20de%20Queiroz.pdf.jpg | * |
dc.thumbnail.url | https://tede.ufrrj.br/retrieve/16508/2013%20-%20Ana%20Paula%20Antunes%20de%20Queiroz.pdf.jpg | * |
dc.thumbnail.url | https://tede.ufrrj.br/retrieve/22834/2013%20-%20Ana%20Paula%20Antunes%20de%20Queiroz.pdf.jpg | * |
dc.thumbnail.url | https://tede.ufrrj.br/retrieve/29184/2013%20-%20Ana%20Paula%20Antunes%20de%20Queiroz.pdf.jpg | * |
dc.thumbnail.url | https://tede.ufrrj.br/retrieve/35532/2013%20-%20Ana%20Paula%20Antunes%20de%20Queiroz.pdf.jpg | * |
dc.thumbnail.url | https://tede.ufrrj.br/retrieve/41894/2013%20-%20Ana%20Paula%20Antunes%20de%20Queiroz.pdf.jpg | * |
dc.thumbnail.url | https://tede.ufrrj.br/retrieve/48318/2013%20-%20Ana%20Paula%20Antunes%20de%20Queiroz.pdf.jpg | * |
dc.thumbnail.url | https://tede.ufrrj.br/retrieve/54748/2013%20-%20Ana%20Paula%20Antunes%20de%20Queiroz.pdf.jpg | * |
dc.originais.uri | https://tede.ufrrj.br/jspui/handle/jspui/3452 | |
dc.originais.provenance | Submitted by Sandra Pereira (srpereira@ufrrj.br) on 2020-04-23T01:27:15Z No. of bitstreams: 1 2013 - Ana Paula Antunes de Queiroz.pdf: 1590390 bytes, checksum: 48c901ea99e4edbbbb1b0421d2850d4f (MD5) | eng |
dc.originais.provenance | Made available in DSpace on 2020-04-23T01:27:15Z (GMT). No. of bitstreams: 1 2013 - Ana Paula Antunes de Queiroz.pdf: 1590390 bytes, checksum: 48c901ea99e4edbbbb1b0421d2850d4f (MD5) Previous issue date: 2013-09-25 | eng |
Appears in Collections: | Mestrado em Medicina Veterinária (Patologia e Ciências Clínicas) |
Se for cadastrado no RIMA, poderá receber informações por email.
Se ainda não tem uma conta, cadastre-se aqui!
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
2013 - Ana Paula Antunes de Queiroz.pdf | 2013 - Ana Paula Antunes de Queiroz | 1.55 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.